A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. [electronic resource]
Producer: 19951207Description: 1528-33 p. digitalISSN:- 0028-4793
- Adult
- Antiviral Agents -- adverse effects
- CD4 Lymphocyte Count -- drug effects
- Double-Blind Method
- Female
- HIV Core Protein p24 -- blood
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- adverse effects
- HIV-1 -- drug effects
- Humans
- Male
- RNA, Viral -- blood
- Ritonavir
- Thiazoles -- adverse effects
- Treatment Outcome
- Valine -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.